E.S. Newlands

13.4k citations

164 papers · 9.4k indexed · 1 hit paper · h-index 55

Impact in

Pediatrics, Perinatology and Child Health top 0.1%
- Prenatal Screening and Diagnostics
Genetics top 0.5%
- Glioma Diagnosis and Treatment

Papers in

Public Health, Environmental and Occupational Health 91
- Gestational Trophoblastic Disease Studies 89
- Ectopic Pregnancy Diagnosis and Management 28
Pediatrics, Perinatology and Child Health 55
- Prenatal Screening and Diagnostics 48

Co-authors: Gordon Rustin K. D. Bagshawe Rosemary A. Fisher Richard H. J. Beǵent L. Holden Marianne Foskett F.J. Paradinas C. Brock
Journals: British Journal of Cancer (21 papers)BJOG An International Journal of Obstetrics & Gynaecology (11 papers)Journal of Clinical Oncology (11 papers)European Journal of Cancer (7 papers)The Lancet (7 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

E.S. Newlands

163 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials 1997 · 631 citations

Peers

Countries citing papers authored by E.S. Newlands

Since Specialization

Citations

This map shows the geographic impact of E.S. Newlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.S. Newlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.S. Newlands more than expected).

Fields of papers citing papers by E.S. Newlands

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.S. Newlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.S. Newlands. The network helps show where E.S. Newlands may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E.S. Newlands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.S. Newlands Line = papers co-authored together E.S. Newlands links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of deletions in 7q11.2 and 8p12–p21 as prognostic indicators of tumour development following molar pregnancy Gynecologic Oncology ·Beverley Burke, Neil J. Sebire, Jill Moss, Matt Hodges, Michael J. Seckl, E.S. Newlands, Rosemary A. Fisher	2006	15
2	High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia British Journal of Cancer ·Andrew Lawrence, Michael J. Seckl, L. Alexandrova, Linda Evans, Paul Lorigan, S Pors Nielsen, Edward Kanfer, E.S. Newlands, Barry W. Hancock	2005	37
3	Gestational trophoblastic neoplasia: The management of relapsing patients and other recent advances Current Oncology Reports ·Naveed Sarwar, E.S. Newlands, Michael J. Seckl	2004	9
4	Phase 1 study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas British Journal of Cancer ·E.S. Newlands, Theresa Foster, Sara Zaknoen	2003	30
5	Risk of partial and complete relation hydatidiform molar pregnancy in to maternal age UCL Discovery (University College London) ·Neil J. Sebire, Marianne Foskett, R. Fisher, Helen C. Rees, Michael J. Seckl, E.S. Newlands	2002	1
6	Pseudo‐partial moles: placental stem vessel hydrops and the association with Beckwith–Wiedemann syndrome and complete moles Histopathology ·F.J. Paradinas, Neil J. Sebire, Rosemary A. Fisher, Helen C. Rees, Marianne Foskett, Michael J. Seckl, E.S. Newlands	2001	86
7	Choriocarcinoma and partial hydatidiform moles The Lancet ·Michael J. Seckl, Rosemary A. Fisher, Giovanni Salerno, Helene C. Rees, F.J. Paradinas, Marianne Foskett, E.S. Newlands	2000	242
8	Phase I trial of temozolomide using an extended continuous oral schedule. PubMed ·C. Brock, E.S. Newlands, Stephen R. Wedge, Mark Bower, Helen Evans, Iain Colquhoun, Mary E. Roddie, M.G. Glaser, Mehdi Boudjadja, Gordon Rustin	1998	228
9	Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years European Journal of Cancer ·Mark Bower, Gordon Rustin, E.S. Newlands, L. Holden, D Short, Marianne Foskett, K. D. Bagshawe	1998	58
10	Effect of single and multiple administration of an O ? 6 -benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model Cancer Chemotherapy and Pharmacology ·Stephen R. Wedge, Constantin Alajalov, E.S. Newlands	1997	52
11	Surveillance policy for stage I ovarian germ cell tumors. Journal of Clinical Oncology ·G. Dark, Mark Bower, E.S. Newlands, F.J. Paradinas, G.J.S. Rustin	1997	83
12	Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treatment Reviews ·E.S. Newlands, M. F. G. STEVENS, Stephen R. Wedge, Richard T. Wheelhouse, C. Brock Hit paper breakdown →	1997	631
13	Health-related quality of life (HQL) measurement in patients with brain cancer (Meeting abstract). Rehabilitation Oncology ·Neil K. Aaronson, David Osoba, W.K. Alfred Yung, M. Brada, E.S. Newlands, Vega Gutiérrez M, K.C.A. Sneeuw	1997	1
14	The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial British Journal of Cancer ·Patrick McHugh, Shôn Lewis, Sarah Ford, E.S. Newlands, Gordon Rustin, R. Charles Coombes, Dean Smith, Séamus O’Reilly, Lesley Fallowfield	1995	88
15	Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells British Journal of Cancer ·J Baer, Andrea Freeman, E.S. Newlands, Amanda J. Watson, Joseph A. Rafferty, GP Margison	1993	171
16	Physicians' Perceptions of Anxiety and Depression among Their Outpatients: Relationships with Patients and Doctors' Satisfaction with Their Interviews Journal of the Royal College of Physicians of London ·Tom Sensky, Duffy, Amy Gilbert, Richard H. J. Beǵent, E.S. Newlands, Gordon Rustin, Caroline A. Thompson	1989	27
17	Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. Journal of Clinical Oncology ·Gordon Rustin, E.S. Newlands, Richard H. J. Beǵent, J. Dent, K. D. Bagshawe	1989	107
18	Single agent etoposide in gestational trophoblastic tumours European Journal of Cancer and Clinical Oncology ·R. N. HITCHINS, L. Holden, E.S. Newlands, Richard H. J. Beǵent, Gordon Rustin, K. D. Bagshawe	1988	13
19	Successful management of metastatic and primary germ cell tumors in the brain Cancer ·Ghazala Akbar Jamali, E.S. Newlands, Kenneth D. Bagshawe, XinchengAN, S. M. Crawford	1986	86
20	Oncology Supplement: Scientific Foundations of Oncology Journal of the Royal Society of Medicine ·E.S. Newlands	1981	2

About E.S. Newlands

E.S. Newlands is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Genetics, Reproductive Medicine and Neurology, having authored 164 papers that have together received 9.4k indexed citations. Recurring topics across this work include Gestational Trophoblastic Disease Studies (89 papers), Prenatal Screening and Diagnostics (48 papers), Testicular diseases and treatments (37 papers), Ectopic Pregnancy Diagnosis and Management (28 papers), Neuroblastoma Research and Treatments (17 papers), Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (9 papers) and Ovarian cancer diagnosis and treatment (9 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.5k citations), Genetics (1.8k citations), Public Health, Environmental and Occupational Health (4.3k citations), Reproductive Medicine (737 citations) and Oncology (1.4k citations). E.S. Newlands has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gordon Rustin, K. D. Bagshawe, Rosemary A. Fisher, Richard H. J. Beǵent, L. Holden, Marianne Foskett, F.J. Paradinas, C. Brock, M. F. G. STEVENS and Mark Bower. Their work appears in journals such as British Journal of Cancer, BJOG An International Journal of Obstetrics & Gynaecology, Journal of Clinical Oncology, European Journal of Cancer and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact